Company / Interest Expense
Zivo Bioscience, Inc. Interest Expense History
FY2013-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$23.8K
FY2023
5-year range
$13.3K / $97.6K
FY2019-FY2023
Trend
+78.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense returned to growth in FY2023 after 2 years of decline, reaching $23,793.
Based on SEC 10-K filings.
$23,793 in FY2023 with a 3-year CAGR of -37.5%.
Improved from $44,677 to $23,793 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -37.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -37.5%, indicating a declining trend.
- In FY2023, interest expense increased 78.6% year-over-year.
- Peak interest expense was recorded in FY2014.
- Lowest interest expense in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -96.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $23.8K | +78.6% |
| FY2022 | $13.3K | -70.2% |
| FY2021 | $44.7K | -54.2% |
| FY2020 | $97.6K | - |
| FY2019 | - | - |
| FY2016 | -$35.5K | -1378.8% |
| FY2015 | -$2.4K | -100.5% |
| FY2014 | $515.6K | +216.8% |
| FY2013 | -$441.5K | -211.5% |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026